Dr Olaniyi Osuntokun MD, ABPN Double Board-Certified Neuropsychiatrist, Psychiatrist and Neurologist
Psychiatrist in Lafayette, Indianapolis | Statewide Indiana Telehealth
Dr Olaniyi Osuntokun, MD, is the Medical Director and Supervising Psychiatrist at IN Focus First, where he leads a highly specialized, multidisciplinary team dedicated to delivering precision, telehealth-based psychiatric care across the state of Indiana. With over two decades of rigorous clinical experience, Dr Osuntokun holds the rare and distinguished credential of being double board-certified by the American Board of Psychiatry and Neurology (ABPN) in both Psychiatry and Neurology. This dual expertise allows him to bridge the critical gap between the structural, biological science of the nervous system and the behavioral complexities of mental health, providing patients with a truly comprehensive medical perspective.
At IN Focus First, Dr Osuntokun (NPI 1548375058) champions the “Psychiatry Simplified” philosophy. He firmly believes that while psychiatric science and neurobiology are inherently complex, the patient’s journey to healing should be accessible, highly empathetic, and completely free from the exhausting friction of traditional clinic wait times and rigid scheduling. Under his direct medical oversight, the practice provides thorough, sixty-minute diagnostic evaluations, moving far beyond the superficial, fifteen-minute medication checks that dominate the current healthcare landscape.
Dr Osuntokun specializes in the meticulous assessment and treatment of complex, overlapping psychiatric conditions. His clinical focus encompasses Adult psychiatric evaluations and Adolescent ADHD, Bipolar Spectrum Disorders, Treatment-Resistant Depression, severe anxiety, psychosis, obsessive-compulsive disorder (OCD), and trauma-informed care, including dedicated support for Veteran health. He possesses a profound clinical understanding of how executive dysfunction and neurodivergence—particularly late-diagnosed ADHD in high-achieving adults and women with ADHD over the age of thirty—can frequently masquerade as generalized anxiety, major depression, or chronic professional burnout.
As a pioneer in Integrative and Metabolic Psychiatry, Dr Osuntokun recognizes that mental health cannot be effectively treated in a biological vacuum. He leverages advanced, objective functional diagnostics, including GeneSight pharmacogenomic testing to identify the root biological causes of psychiatric distress. By rigorously analyzing the Microbiome-Gut-Brain axis, hormone-driven mood fluctuations such as Premenstrual Dysphoric Disorder (PMDD), and hypothalamic-pituitary-adrenal (HPA) axis exhaustion, he effectively removes the frustrating trial-and-error phase of psychopharmacology. This metabolic approach ensures that patients receive the exact neurochemical support their specific genetic biology requires.
Furthermore, Dr Osuntokun is a leading regional expert in the specialized field of Clinical Deprescribing. He designs safe, medically supervised, and highly individualized tapering protocols for patients seeking to carefully reduce their psychiatric medication burden, utilizing his deep neurological insight to maintain optimal brain stability and mitigate withdrawal syndromes throughout the entire process.
Dr Osuntokun earned his foundational medical degree from the prestigious University of Ibadan College of Medicine, an institution globally recognized for its contributions to neurological research, before completing his medical internship and psychiatric residency at the Indiana University School of Medicine and Indiana University Hospital and Clinics.
His ongoing commitment to the Indiana healthcare ecosystem is extensive; in addition to his executive leadership at IN Focus First, he serves as an Associate Medical Director for GuideStar Eldercare, overseeing psychiatric care in long-term facilities, and maintains active clinical affiliations with leading regional institutions, including Ascension St. Vincent Hospital and Lutheran Hospital of Indiana and serves as Medical Director at Sycamore Spring Hospital in Lafayette, Indiana.
A dedicated clinical thought leader and active researcher, Dr Osuntokun has authored peer-reviewed publications indexed in major medical databases on topics ranging from the epidemiology of major neurocognitive disorders to the efficacy of advanced combination therapies for treatment-resistant depression. He frequently serves as the lead medical reviewer and primary author for the IN Focus First clinical library, publishing expert, patient-facing guidance on the unique neurobiology of ADHD focus, the systemic impact of low cortisol, and the complexities of psychotropic medication interactions.
He is a fully verified medical provider on Doximity, maintains a highly rated clinical profile on Healthgrades, and is a recognized 2026 Professional Member of CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder).
Through secure, HIPAA-compliant telehealth infrastructure, Dr Osuntokun and his multidisciplinary team provide fast, priority access to exceptional, root-cause psychiatric care for patients throughout Northern, Central, and Southern Indiana, including dedicated, expedited support for university students at Purdue University and Indiana University while directly collaborating with Jessica Walsh, PMHNP, PhD.
Clinical Reference FAQ: Dr Olaniyi Osuntokun, MD
How does Dr Osuntokun’s dual board certification in Psychiatry and Neurology influence clinical outcomes for Indiana residents?
Dr Olaniyi Osuntokun, MD, is double board-certified by the American Board of Psychiatry and Neurology (ABPN) in both Psychiatry and Neurology. This dual specialization provides a specific clinical framework for Indiana patients, allowing for the integration of structural neurobiology with behavioral pathology. By leveraging his residency training at the Indiana University School of Medicine, Dr Osuntokun evaluates mental health through the lens of the autonomic nervous system and neuro metabolic stability. This expertise is particularly indicated for complex cases where psychiatric symptoms may be driven by hormonal dysregulation, HPA axis exhaustion, or neuro-inflammatory pathways, ensuring diagnostic accuracy beyond standard behavioral checklists.
What is the clinical framework for the medical tapering and deprescribing services provided at IN Focus First?
Under the medical direction of Dr Osuntokun (NPI: 1548375058), the practice utilizes a specialized Clinical Deprescribing protocol. This service provides medically supervised, gradual tapering schedules for patients seeking to reduce their psychotropic medication burden while prioritizing neurological and hormonal stability. Dr Osuntokun utilizes his dual training in Neurology and Psychiatry to monitor for signs of withdrawal syndrome and affective destabilization. The process involves comprehensive diagnostic reviews and metabolic oversight to ensure that the reduction of benzodiazepines, antidepressants, or stimulants follows evidence-based guidelines for neuro-restoration and long-term restorative health for residents throughout Northern, Central, and Southern Indiana.
How does the practice maintain compliance with the Ryan Haight Act and Indiana Code § 25-1-9.5 regarding the remote management of controlled substances?
Dr Osuntokun maintains strict adherence to the Ryan Haight Online Pharmacy Consumer Protection Act (21 U.S.C. § 829(e)) and Indiana Code § 25-1-9.5 for all telehealth-based psychiatric services. Controlled substances, including stimulant medications for ADHD such as Adderall and Vyvanse, are only managed following a comprehensive 60-minute initial psychiatric evaluation and verified DSM-5-TR diagnosis. As an Indiana-licensed physician affiliated with Ascension St. Vincent Hospital-Indianapolis, Dr Osuntokun ensures that all remote prescribing meets federal and state medical standards. This includes regular tele-optimization visits and objective diagnostics to verify clinical efficacy and patient safety within the secure, HIPAA-compliant virtual infrastructure.
How are pharmacogenomic and metabolic diagnostics integrated into the precision psychiatry model under Dr Osuntokun’s medical oversight?
Dr Osuntokun integrates advanced functional diagnostics to eliminate the “trial-and-error” phase of psychopharmacology. The precision model incorporates GeneSight® pharmacogenomic testing to map a patient’s genetic response to medications based on receptor binding profiles and metabolic rate. Additionally, whole-body lab testing identifies underlying biological stressors, such as hormone-driven mood fluctuations (PMDD). By correlating genetic data with clinical observations, Dr Osuntokun provides individualized treatment plans that address the root neuro-metabolic causes of treatment-resistant depression and anxiety, ensuring that pharmacological interventions are biologically matched to the patient’s unique physiological environment and genetic profile.